Kelly Deck
Executive Director, Finance
Account
Apricus Biosciences
United States of America
Biography
Kelly Deck joined the finance team as Director of SEC Reporting in July 2013. Prior to Apricus, Ms. Deck held various roles in the accounting and finance departments for pharmaceutical and biotechnology companies, such as at Gen-Probe, Inc., which was acquired by Hologic, Inc. in August 2012, as well as La Jolla Pharmaceutical Company, Inc. and Cytori Therapeutics, Inc. Before transitioning to private industry, Ms. Deck began her career in public accounting for a local firm in Atlanta, Georgia. Ms. Deck holds a Bachelor of Business Administration in Accounting and a Master of Science in Accounting, both from the University of Cincinnati. She is an active licensed CPA in California.
Research Interest
Accounting
